journal article·2006-04

Intact surface of bioactive glass S53P4 is resistant to osteoclastic activity

Timothy Wilson, Vilhelmiina Parikka, Johanna Holmbom, Heimo Ylänen, Risto Penttinen

Publisher page

Abstract

Abstract Bioactive glass reacts with body fluids and is gradually dissolved in tissues and in cell cultures. We investigated whether osteoclasts contribute to this process, by culturing newborn rat bone‐marrow cells containing osteoclasts on polished bioactive glass plates (glass S53P4). The cultures were inspected at days 1–5 and stained for alkaline phosphatase (ALP) to demonstrate osteoblasts and for tartrate resistant acid phosphatase (TRAP) to visualize osteoclasts. Nonosteoclastic cells proliferated several‐fold both on bioactive glass and on plastic, whereas osteoclasts and their precursors matured into multicellular giant cells and degenerated. Most cells on bioactive glass became ALP‐positive, whereas on plastic the majority of cells remained ALP‐negative. Osteoclasts survived on bioactive glass for 4–5 days, whereas on plastic they degenerated and disappeared after 3 days. Condensed nuclei indicating apoptosis were detected both in degenerating osteoclasts and osteoblasts. The surface of the bioactive glass reacted rapidly forming rounded pits, erosions, and cracks within 24 h in areas occupied by osteoblasts. Light microscopy and scanning electron micrographs demonstrated, however, a smooth surface below the cytoplasm of osteoclasts. This indicates that when applied on an intact bioactive glass surface, osteoclasts were unable to dissolve the glass material within this culture period. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone health and osteoporosis research · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. 10.1016/0022-3093(91)90090-S10.1016/0022-3093(91)90090-S ↗
2. Hench LL · 1994 · 3
3. 10.1163/15685620432300535210.1163/156856204323005352 ↗
4. 10.1023/A:100895500295510.1023/A:1008955002955 ↗
5. 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E ↗
6. 10.1002/jbm.82029030710.1002/jbm.820290307 ↗
7. 10.1002/jbm.a.3004810.1002/jbm.a.30048 ↗
8. 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.0.CO;2-J10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.0.CO;2-J ↗
9. 10.1007/BF0070528310.1007/BF00705283 ↗
10. Heikkilä JT · 1995 · 35
11. 10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-110.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1 ↗
12. 10.1002/jbm.b.1002310.1002/jbm.b.10023 ↗
13. 10.1016/S0232-1513(84)80078-X10.1016/S0232-1513(84)80078-X ↗
14. 10.1002/jbm.82022110810.1002/jbm.820221108 ↗
15. 10.1002/(SICI)1097-4636(199710)37:1<137::AID-JBM17>3.0.CO;2-D10.1002/(SICI)1097-4636(199710)37:1<137::AID-JBM17>3.0.CO;2-D ↗
16. 10.1016/0142-9612(87)90115-310.1016/0142-9612(87)90115-3 ↗
17. Extracellular matrix production by osteoblasts on bioactive substrata in vitro
18. 10.1016/0142-9612(92)90044-O10.1016/0142-9612(92)90044-O ↗
19. 10.1002/jbm.82027040710.1002/jbm.820270407 ↗
20. 10.1002/jcb.24056020710.1002/jcb.240560207 ↗
21. 10.1002/jbm.82029031110.1002/jbm.820290311 ↗
22. 10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C ↗
23. 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I ↗
24. 10.1002/1097-4636(20001215)52:4<783::AID-JBM24>3.0.CO;2-J10.1002/1097-4636(20001215)52:4<783::AID-JBM24>3.0.CO;2-J ↗
25. 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
26. 10.1016/j.biomaterials.2004.09.05910.1016/j.biomaterials.2004.09.059 ↗
27. Type I collagen production by osteoblast‐like cells cultured in contact with different bioactive glasses
28. 10.1002/jbm.128210.1002/jbm.1282 ↗
29. 10.1016/j.biomaterials.2003.10.07910.1016/j.biomaterials.2003.10.079 ↗
30. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes
31. Porous bioactive glass matrix in reconstruction of articular osteochondral defects
32. 10.1002/jbm.a.1050110.1002/jbm.a.10501 ↗
33. 10.1002/path.171127020210.1002/path.1711270202 ↗
34. 10.1007/BF0223948010.1007/BF02239480 ↗
35. 10.1172/JCI1204010.1172/JCI12040 ↗
36. Integrin function in osteoclasts
37. 10.1006/bbrc.1999.071510.1006/bbrc.1999.0715 ↗
38. 10.1023/A:102297162982210.1023/A:1022971629822 ↗
39. 10.1016/S0099-2399(06)80094-410.1016/S0099-2399(06)80094-4 ↗
40. 10.1002/(SICI)1097-4636(200005)50:2<153::AID-JBM9>3.0.CO;2-R10.1002/(SICI)1097-4636(200005)50:2<153::AID-JBM9>3.0.CO;2-R ↗
41. 10.1002/(SICI)1097-4636(199811)42:2<278::AID-JBM13>3.0.CO;2-F10.1002/(SICI)1097-4636(199811)42:2<278::AID-JBM13>3.0.CO;2-F ↗
42. 10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R ↗
43. Vaahtio M · 2005 · 549
44. 10.1089/ten.2005.11.47910.1089/ten.2005.11.479 ↗